Cargando…

Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That’s the Question

Detalles Bibliográficos
Autores principales:	Jin, Qi, Guan, Lihua, Pan, Wenzhi, Zhang, Xiaochun, Chen, Dandan, Zhou, Daxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2022
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9872803/ https://www.ncbi.nlm.nih.gov/pubmed/35353031 http://dx.doi.org/10.1164/rccm.202112-2721LE

Ejemplares similares

Reply to Jin et al.: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That’s the Question
por: Nathan, Steven D.
Publicado: (2022)

Initial Triple Combination Therapy for Intermediate-and High-Risk Pulmonary Arterial Hypertension: Standard of Care or Still Too Soon to Tell?
por: Jin, Qi, et al.
Publicado: (2021)

Characterisation of cough evoked by inhaled treprostinil and treprostinil palmitil
por: Chapman, Richard W., et al.
Publicado: (2021)

To Defend or Not To Defend: That’s the Question
por: Varahan, Sriram, et al.
Publicado: (2016)

TB or not TB! That’s the question
por: Nugud, Ahmed, et al.
Publicado: (2019)

Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension
por: Raina, Amresh, et al.
Publicado: (2013)

Inhaled treprostinil: a therapeutic review
por: Channick, Richard N, et al.
Publicado: (2012)

Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)

MELAS or Leigh syndrome, that’s the question
por: Finsterer, Josef
Publicado: (2021)

Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
por: Gauani, Helena, et al.
Publicado: (2023)

Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients
por: McSweeney, Julia, et al.
Publicado: (2023)

The Antifibrotic Effects of Inhaled Treprostinil: An Emerging Option for ILD
por: Kolb, Martin, et al.
Publicado: (2022)

Gaucher Cells or Pseudo-Gaucher Cells: That’s the Question
por: Gören Şahin, Deniz, et al.
Publicado: (2014)

Rapid Transition from Inhaled Iloprost to Inhaled Treprostinil in Patients with Pulmonary Arterial Hypertension
por: Bourge, Robert C, et al.
Publicado: (2013)

Medical Management of Pulmonary Arterial Hypertension: Current Approaches and Investigational Drugs
por: Jin, Qi, et al.
Publicado: (2023)

INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH)
por: Hill, Nicholas S., et al.
Publicado: (2022)

Efficacy, safety, and pharmacokinetics of inhaled treprostinil in Japanese patients with pulmonary arterial hypertension
por: Kuwana, Masataka, et al.
Publicado: (2023)

Staphylococcus aureus type I signal peptidase: essential or not essential, that’s the question
por: Hazenbos, Wouter L., et al.
Publicado: (2017)

Combination therapy with riociquat and inhaled treprostinil in inoperable and progressive chronic thromboembolic pulmonary hypertension
por: Swisher, John W., et al.
Publicado: (2016)

The safety and tolerability of inhaled treprostinil in patients with pulmonary hypertension and chronic obstructive pulmonary disease
por: Bajwa, Abubakr A., et al.
Publicado: (2017)

Development and Characterization of Treprostinil Palmitil Inhalation Aerosol for the Investigational Treatment of Pulmonary Arterial Hypertension
por: Plaunt, Adam J., et al.
Publicado: (2021)

Inhaled Treprostinil in Pulmonary Hypertension in the Context of Interstitial Lung Disease: A Success, Finally
por: Behr, Jürgen
Publicado: (2021)

To Stop or Not to Stop, That’s the Question: About Persistence and Mood of Workaholics and Work Engaged Employees
por: Van Wijhe, Corine I., et al.
Publicado: (2011)

“To be or not to be Retained … That’s the Question!” Retention, Self-esteem, Self-concept, Achievement Goals, and Grades
por: Peixoto, Francisco, et al.
Publicado: (2016)

High-dose glucocorticoid before hip and knee arthroplasty: To use or not to use—that’s the question
por: Kehlet, Henrik, et al.
Publicado: (2018)

Annuloplasty for mitral valve repair in degenerative disease: to be flexible or to be rigid? That’s still the question
por: Bruno, Vito Domenico, et al.
Publicado: (2020)

Treprostinil for pulmonary hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2008)

Ictogenesis? That’s Random…..
por: Ryner, Rachael, et al.
Publicado: (2022)

Bolus or continuous hydrocortisone – that is the question
por: Weber-Carstens, Steffen, et al.
Publicado: (2007)

A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil
por: Zwicke, Diane L., et al.
Publicado: (2021)

Brazilian science under continuous attack
por: Galvão-Castro, Bernardo, et al.
Publicado: (2022)

DNA Damage after Continuous Irradiation: Yanch and Engelward Respond
por: Yanch, Jacquelyn, et al.
Publicado: (2012)

Valethamate bromide: Conflicting evidence and continuing use
por: Babu, Thirunavukkarasu Arun, et al.
Publicado: (2010)

Lt.-Col. Spencer's Case of Continued Fever
por: McNaught, J. G.
Publicado: (1900)

LOVIT or leave it: The vitamin C debate continues
por: Lankadeva, Yugeesh R., et al.
Publicado: (2023)

That’s a matter for ALICE!
por: Katarina Anthony
Publicado: (2010)

That’s All She Wrote
por: Seidman, Charlotte S.
Publicado: (2022)

Implementing the EXPEDITE parenteral induction protocol: Rapid parenteral treprostinil titration and transition to oral treprostinil
por: Kingrey, John F., et al.
Publicado: (2023)

Treatment satisfaction is associated with improved quality of life in patients treated with inhaled treprostinil for pulmonary arterial hypertension
por: Chen, Hubert, et al.
Publicado: (2013)

The removal of cystatin C during continuous venovenous hemofiltration
por: Bouman, Catherine S. C., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_kbu7oclhgkqe5fu8eugtage2c6